Cullinan Therapeutics CGEM
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.17M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 51.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 16.45% to 12.32% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Fisher Investments | Mutual Fund | 2026/Q3 | +764,963 | 1.2% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +144,015 | 0.4% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +98,240 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +96,336 | 0.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +86,547 | 8.2% |
| Ellsworth Advisors, LLC | Mutual Fund | 2026/Q3 | +74,856 | 0.1% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +2,083,073 | 15.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,796,231 | 5.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,124,512 | 5.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +782,800 | 8.1% |
| Boone Capital Management LLC | Hedge Fund | 2026/Q3 | +704,442 | 1.1% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +700,000 | 2.9% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +658,387 | 3.6% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +536,382 | 1.5% |
| Perceptive Advisors LLC | VC/PE Fund | 2026/Q3 | +426,478 | 0.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 4 Nov 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -195 | $12.36 | 158,649 |
| 4 Nov 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -3,805 | $12.36 | 158,649 |
| 7 Sep 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -4,000 | $21.57 | 158,844 |
| 7 Sep 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -4,000 | $21.57 | 158,844 |
| 12 Aug 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -30,000 | $20.26 | 162,844 |
| 5 Jul 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -4,000 | $17.82 | 162,844 |
| 5 Jul 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -4,000 | $17.82 | 162,844 |
| 29 Jun 2026 | Mary Fenton | Chief Financial Officer | Other Acquisition | +1,541 | $8.60 | 14,171 |
| 29 Jun 2026 | Jacquelyn Sumer | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | Other Acquisition | +2,470 | $8.60 | 60,226 |
| 15 Jun 2026 | Stephen Webster | Independent Director | Other Derivative Acquisition | +25,319 | $13.55 | 25,319 |
| 15 Jun 2026 | Anthony Rosenberg | Independent Chairperson | Other Derivative Acquisition | +25,319 | $13.55 | 25,319 |
| 15 Jun 2026 | Mary Thistle | Director | Other Derivative Acquisition | +25,319 | $13.55 | 25,319 |
| 15 Jun 2026 | Andrew Allen | Director | Other Derivative Acquisition | +21,781 | $13.55 | 21,781 |
| 15 Jun 2026 | David Meek | Independent Director | Other Derivative Acquisition | +25,319 | $13.55 | 25,319 |
| 15 Jun 2026 | Mittie Doyle | Director | Other Derivative Acquisition | +21,781 | $13.55 | 21,781 |
| 4 May 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -4,000 | $15.58 | 166,844 |
| 4 May 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -4,000 | $14.60 | 166,844 |
| 4 Mar 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -4,000 | $15.68 | 170,844 |
| 4 Mar 2026 | Jennifer Michaelson | Chief Scientific Officer | Derivative Exercise and Sale | -4,000 | $15.68 | 170,844 |
| 24 Feb 2026 | Jennifer Michaelson | Chief Scientific Officer | Automatic Disposition | -1,780 | $14.14 | 174,844 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 7,928,668 | 12.3% | 13.3 |
| 15 Oct 2026 | 7,640,003 | 11.9% | 8.2 |
| 30 Sep 2026 | 7,634,127 | 11.9% | 5.1 |
| 15 Sep 2026 | 9,629,017 | 15.0% | 10.9 |
| 31 Aug 2026 | 10,371,763 | 16.1% | 15.5 |
| 14 Aug 2026 | 10,588,430 | 16.5% | 15.5 |
No comments yet — be the first to weigh in on CGEM.
Sign in to join the discussion.